US Patent 8309094 Antibody-drug conjugates
Patent 8309094 was granted and assigned to Wyeth on November, 2012 by the United States Patent and Trademark Office.
All edits
Edits on 29 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08309094 Antibody-drug conjugates US Patent 8309094 Antibody-drug conjugates
Infobox
Patent Number
0830909400
Patent Number
830909400
Edits on 22 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083090940
Date of Patent
November 13, 2012
0Patent Application Number
134357310
Date Filed
March 30, 2012
0Patent Primary Examiner
Edits on 23 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083090940
Date of Patent
November 13, 2012
0Patent Application Number
134357310
Date Filed
March 30, 2012
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08309094 Antibody-drug conjugates
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08309094
Date of patent
November 13, 2012
Patent application number
13435731
Date Filed
March 30, 2012
Patent primary examiner
Find more entities like US Patent 8309094 Antibody-drug conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.